InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,599.60
(
1.04%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.66
(
0.22%
)
Bitcoin
63,402.77
(
0.37%
)
Post# of 7536
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next

ash111

Send PM Follow Ignore
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

ash111

Re: kei post# 2771

Monday, 05/08/2017 4:10:35 PM

Monday, May 08, 2017 4:10:35 PM

Post# of 7536
MRNS 1.24, I might bet on this one: https://seekingalpha.com/article/4057179-marinus-pharmaceuticals-will-ganaxolone-succeed-time

Near-term Catalysts:

# Initiate Phase 2 study in women with postpartum depression (PPD) in 1H 2017

# Report top-line data from children with genetic seizure disorders in mid-2017

# Initiate Phase 2 study in patients with status epilepticus (SE) in 2H 2017

"At March 31, 2017, the Company had cash, cash equivalents and investments of $24.8 million, compared to $30.1 million at December 31, 2016.  The Company believes that its cash, cash equivalents and investments, as of March 31, 2017, are adequate to fund operations into the second half of 2018".

Trading at Cash On Hand. Remained me aqxp (If it succeeds).My type risk/reward here.

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up